Norja - norja - Statens legemiddelverk

mylan ab - zopiklon - tablett, filmdrasjert - 7.5 mg

Norja - norja - Statens legemiddelverk

karo pharma oslo as - paracetamol / koffein - tablett - 500 mg / 65 mg

Euroopan unioni - norja - EMA (European Medicines Agency)

eurocept international b. v. - sodium phenylbutyrate - carbamoyl-fosfat syntase jeg mangel sykdom - ulike alimentary tract and metabolism products - behandling av kronisk ledelse av urea-syklus lidelser.

Euroopan unioni - norja - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - ziconotid - injections, spinal; pain - analgetika - ziconotid er indisert for behandling av alvorlig kronisk smerte hos pasienter som krever intratekal (it) analgesi.

Norja - norja - Statens legemiddelverk

abacus medicine a/s - zikonotidacetat - infusjonsvæske, oppløsning - 100 mikrog/ ml

Euroopan unioni - norja - EMA (European Medicines Agency)

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastiske midler - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.